Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
SNDA vs BKD vs ENSG vs SHC vs ADUS
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Medical - Care Facilities
Medical - Diagnostics & Research
Medical - Care Facilities
SNDA vs BKD vs ENSG vs SHC vs ADUS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities | Medical - Care Facilities | Medical - Diagnostics & Research | Medical - Care Facilities |
| Market Cap | $695M | $3.22B | $10.18B | $4.47B | $1.81B |
| Revenue (TTM) | $381M | $3.11B | $5.27B | $1.19B | $1.45B |
| Net Income (TTM) | $-71M | $-205M | $363M | $118M | $100M |
| Gross Margin | -8.0% | 14.3% | 15.2% | 55.3% | 32.5% |
| Operating Margin | -15.3% | 1.4% | 8.5% | 34.9% | 9.8% |
| Forward P/E | — | — | 23.2x | 16.3x | 14.1x |
| Total Debt | $690M | $6.66B | $4.15B | $2.27B | $209M |
| Cash & Equiv. | $11M | $279M | $504M | $346M | $82M |
SNDA vs BKD vs ENSG vs SHC vs ADUS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Sonida Senior Livin… (SNDA) | 100 | 280.3 | +180.3% |
| Brookdale Senior Li… (BKD) | 100 | 319.7 | +219.7% |
| The Ensign Group, I… (ENSG) | 100 | 242.5 | +142.5% |
| Sotera Health Compa… (SHC) | 100 | 57.9 | -42.1% |
| Addus HomeCare Corp… (ADUS) | 100 | 98.0 | -2.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SNDA vs BKD vs ENSG vs SHC vs ADUS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SNDA has the current edge in this matchup, primarily because of its strength in growth and dividends.
- 25.2% revenue growth vs BKD's 4.8%
- 0.9% yield, 1-year raise streak, vs ENSG's 0.1%, (3 stocks pay no dividend)
BKD ranks third and is worth considering specifically for momentum.
- +105.1% vs ADUS's -13.4%
ENSG is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- 7.5% 10Y total return vs ADUS's 399.9%
- Beta 0.42, yield 0.1%, current ratio 1.42x
- Beta 0.42 vs SHC's 1.32, lower leverage
SHC is the clearest fit if your priority is quality.
- 9.9% margin vs SNDA's -18.7%
ADUS is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 23.2%, EPS growth 23.2%, 3Y rev CAGR 14.4%
- Lower volatility, beta 0.58, Low D/E 19.2%, current ratio 1.80x
- PEG 0.70 vs ENSG's 1.68
- Lower P/E (14.1x vs 16.3x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 25.2% revenue growth vs BKD's 4.8% | |
| Value | Lower P/E (14.1x vs 16.3x) | |
| Quality / Margins | 9.9% margin vs SNDA's -18.7% | |
| Stability / Safety | Beta 0.42 vs SHC's 1.32, lower leverage | |
| Dividends | 0.9% yield, 1-year raise streak, vs ENSG's 0.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +105.1% vs ADUS's -13.4% | |
| Efficiency (ROA) | 7.0% ROA vs SNDA's -8.4%, ROIC 8.8% vs -5.8% |
SNDA vs BKD vs ENSG vs SHC vs ADUS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SNDA vs BKD vs ENSG vs SHC vs ADUS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ADUS leads in 2 of 6 categories
SHC leads 1 • SNDA leads 0 • BKD leads 0 • ENSG leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SHC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ENSG is the larger business by revenue, generating $5.3B annually — 13.8x SNDA's $381M. SHC is the more profitable business, keeping 9.9% of every revenue dollar as net income compared to SNDA's -18.7%. On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $381M | $3.1B | $5.3B | $1.2B | $1.4B |
| EBITDAEarnings before interest/tax | -$1M | $384M | $558M | $517M | $159M |
| Net IncomeAfter-tax profit | -$71M | -$205M | $363M | $118M | $100M |
| Free Cash FlowCash after capex | -$9M | $56M | $406M | $112M | $137M |
| Gross MarginGross profit ÷ Revenue | -8.0% | +14.3% | +15.2% | +55.3% | +32.5% |
| Operating MarginEBIT ÷ Revenue | -15.3% | +1.4% | +8.5% | +34.9% | +9.8% |
| Net MarginNet income ÷ Revenue | -18.7% | -6.6% | +6.9% | +9.9% | +6.9% |
| FCF MarginFCF ÷ Revenue | -2.3% | +1.8% | +7.7% | +9.4% | +9.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.2% | -2.0% | +18.4% | +10.0% | +7.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -3.5% | +89.7% | +21.9% | +2.9% | +17.2% |
Valuation Metrics
ADUS leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 18.7x trailing earnings, ADUS trades at a 68% valuation discount to SHC's 58.0x P/E. Adjusting for growth (PEG ratio), ADUS offers better value at 0.93x vs ENSG's 2.16x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $695M | $3.2B | $10.2B | $4.5B | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $9.6B | $13.8B | $6.4B | $1.9B |
| Trailing P/EPrice ÷ TTM EPS | -8.67x | -12.21x | 29.85x | 58.04x | 18.67x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 23.19x | 16.26x | 14.12x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.16x | — | 0.93x |
| EV / EBITDAEnterprise value multiple | — | 25.53x | 25.71x | 21.09x | 12.52x |
| Price / SalesMarket cap ÷ Revenue | 1.82x | 1.03x | 2.01x | 3.84x | 1.28x |
| Price / BookPrice ÷ Book value/share | 11.76x | — | 4.59x | 7.41x | 1.65x |
| Price / FCFMarket cap ÷ FCF | — | — | 27.46x | 29.95x | 17.48x |
Profitability & Efficiency
ADUS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SHC delivers a 20.6% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $-235 for BKD. ADUS carries lower financial leverage with a 0.19x debt-to-equity ratio, signaling a more conservative balance sheet compared to SNDA's 12.26x. On the Piotroski fundamental quality scale (0–9), ADUS scores 7/9 vs SNDA's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -76.4% | -234.5% | +16.6% | +20.6% | +9.3% |
| ROA (TTM)Return on assets | -8.4% | -3.4% | +6.8% | +3.7% | +7.0% |
| ROICReturn on invested capital | -5.8% | +0.2% | +7.0% | +11.8% | +8.8% |
| ROCEReturn on capital employed | -7.7% | +0.3% | +10.2% | +13.3% | +10.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 5 | 6 | 7 |
| Debt / EquityFinancial leverage | 12.26x | — | 1.86x | 3.75x | 0.19x |
| Net DebtTotal debt minus cash | $679M | $6.4B | $3.7B | $1.9B | $127M |
| Cash & Equiv.Liquid assets | $11M | $279M | $504M | $346M | $82M |
| Total DebtShort + long-term debt | $690M | $6.7B | $4.2B | $2.3B | $209M |
| Interest CoverageEBIT ÷ Interest expense | -0.86x | 0.19x | 88.33x | 2.38x | 14.45x |
Total Returns (Dividends Reinvested)
Evenly matched — SNDA and BKD and ENSG each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,324 today (with dividends reinvested), compared to $6,367 for SHC. Over the past 12 months, BKD leads with a +105.1% total return vs ADUS's -13.4%. The 3-year compound annual growth rate (CAGR) favors SNDA at 73.9% vs SHC's 1.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.6% | +25.0% | +0.3% | -11.4% | -8.7% |
| 1-Year ReturnPast 12 months | +52.7% | +105.1% | +27.5% | +19.2% | -13.4% |
| 3-Year ReturnCumulative with dividends | +426.3% | +239.7% | +88.9% | +4.6% | +16.3% |
| 5-Year ReturnCumulative with dividends | -23.8% | +85.2% | +103.2% | -36.3% | +0.0% |
| 10-Year ReturnCumulative with dividends | -87.7% | -26.0% | +752.0% | -37.6% | +399.9% |
| CAGR (3Y)Annualised 3-year return | +73.9% | +50.3% | +23.6% | +1.5% | +5.2% |
Risk & Volatility
Evenly matched — SNDA and ENSG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than SHC's 1.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SNDA currently trades 93.8% from its 52-week high vs ADUS's 78.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.10x | 0.67x | 0.42x | 1.32x | 0.58x |
| 52-Week HighHighest price in past year | $38.98 | $17.00 | $218.00 | $19.85 | $124.44 |
| 52-Week LowLowest price in past year | $23.53 | $6.07 | $133.81 | $10.80 | $90.89 |
| % of 52W HighCurrent price vs 52-week peak | +93.8% | +79.7% | +80.0% | +78.9% | +78.2% |
| RSI (14)Momentum oscillator 0–100 | 63.5 | 54.0 | 23.3 | 56.5 | 49.3 |
| Avg Volume (50D)Average daily shares traded | 602K | 3.3M | 358K | 3.1M | 236K |
Analyst Outlook
Evenly matched — SNDA and ENSG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SNDA as "Hold", BKD as "Buy", ENSG as "Buy", SHC as "Buy", ADUS as "Buy". Consensus price targets imply 40.4% upside for SHC (target: $22) vs -5.2% for SNDA (target: $35). For income investors, SNDA offers the higher dividend yield at 0.85% vs ENSG's 0.14%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $34.67 | $17.67 | $222.33 | $22.00 | $128.67 |
| # AnalystsCovering analysts | 3 | 12 | 13 | 12 | 15 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | — | +0.1% | — | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | 12 | 2 | 2 |
| Dividend / ShareAnnual DPS | $0.31 | — | $0.24 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +0.2% | 0.0% | 0.0% |
ADUS leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). SHC leads in 1 (Income & Cash Flow). 3 tied.
SNDA vs BKD vs ENSG vs SHC vs ADUS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SNDA or BKD or ENSG or SHC or ADUS a better buy right now?
For growth investors, Sonida Senior Living, Inc.
(SNDA) is the stronger pick with 25. 2% revenue growth year-over-year, versus 4. 8% for Brookdale Senior Living Inc. (BKD). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 7x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Brookdale Senior Living Inc. (BKD) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SNDA or BKD or ENSG or SHC or ADUS?
On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.
7x versus Sotera Health Company at 58. 0x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Addus HomeCare Corporation wins at 0. 70x versus The Ensign Group, Inc. 's 1. 68x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SNDA or BKD or ENSG or SHC or ADUS?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +103. 2%, compared to -36. 3% for Sotera Health Company (SHC). Over 10 years, the gap is even starker: ENSG returned +752. 0% versus SNDA's -87. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SNDA or BKD or ENSG or SHC or ADUS?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus Sotera Health Company's 1. 32β — meaning SHC is approximately 213% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Addus HomeCare Corporation (ADUS) carries a lower debt/equity ratio of 19% versus 12% for Sonida Senior Living, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SNDA or BKD or ENSG or SHC or ADUS?
By revenue growth (latest reported year), Sonida Senior Living, Inc.
(SNDA) is pulling ahead at 25. 2% versus 4. 8% for Brookdale Senior Living Inc. (BKD). On earnings-per-share growth, the picture is similar: Sotera Health Company grew EPS 68. 8% year-over-year, compared to -681. 5% for Sonida Senior Living, Inc.. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SNDA or BKD or ENSG or SHC or ADUS?
The Ensign Group, Inc.
(ENSG) is the more profitable company, earning 6. 8% net margin versus -20. 0% for Sonida Senior Living, Inc. — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SHC leads at 33. 8% versus -15. 3% for SNDA. At the gross margin level — before operating expenses — SHC leads at 55. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SNDA or BKD or ENSG or SHC or ADUS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Addus HomeCare Corporation (ADUS) is the more undervalued stock at a PEG of 0. 70x versus The Ensign Group, Inc. 's 1. 68x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14. 1x forward P/E versus 23. 2x for The Ensign Group, Inc. — 9. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SHC: 40. 4% to $22. 00.
08Which pays a better dividend — SNDA or BKD or ENSG or SHC or ADUS?
In this comparison, SNDA (0.
9% yield), ENSG (0. 1% yield) pay a dividend. BKD, SHC, ADUS do not pay a meaningful dividend and should not be held primarily for income.
09Is SNDA or BKD or ENSG or SHC or ADUS better for a retirement portfolio?
For long-horizon retirement investors, The Ensign Group, Inc.
(ENSG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 42), +752. 0% 10Y return). Both have compounded well over 10 years (ENSG: +752. 0%, SHC: -37. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SNDA and BKD and ENSG and SHC and ADUS?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SNDA is a small-cap high-growth stock; BKD is a small-cap quality compounder stock; ENSG is a mid-cap high-growth stock; SHC is a small-cap quality compounder stock; ADUS is a small-cap high-growth stock. SNDA pays a dividend while BKD, ENSG, SHC, ADUS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.